Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-17T17:20:33.306Z Has data issue: false hasContentIssue false
  • English
  • Français

Healthcare-acquired coronavirus disease 2019 (COVID-19) is less symptomatic than community-acquired disease among healthcare workers

Part of: SARS-CoV-2/COVID-19

Published online by Cambridge University Press:  15 April 2021

Jeffrey J. Fletcher Open the ORCID record for Jeffrey J. Fletcher [Opens in a new window] ,
Eric C. Feucht ,
Peter Y. Hahn ,
Theresa N. McGoff ,
Del J. Dehart ,
Mohamad E. El Mortada  and
Ronald G. Grifka
Jeffrey J. Fletcher*
Affiliation:
Critical Care Medicine, Metro Health University of Michigan Health, Wyoming, Michigan Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, Michigan
Eric C. Feucht
Affiliation:
Critical Care Medicine, Metro Health University of Michigan Health, Wyoming, Michigan
Peter Y. Hahn
Affiliation:
Critical Care Medicine, Metro Health University of Michigan Health, Wyoming, Michigan
Theresa N. McGoff
Affiliation:
Department of Research, Metro Health University of Michigan Health, Wyoming, Michigan
Del J. Dehart
Affiliation:
Infectious Diseases, Metro Health University of Michigan Health, Wyoming, Michigan
Mohamad E. El Mortada
Affiliation:
Infectious Diseases, Metro Health University of Michigan Health, Wyoming, Michigan
Ronald G. Grifka
Affiliation:
Department of Research, Metro Health University of Michigan Health, Wyoming, Michigan
*
Author for correspondence: Jeffrey J. Fletcher, E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

We hypothesized that healthcare workers (HCWs) with high-risk exposures outside the healthcare system would have less asymptomatic coronavirus 2019 (COVID-19) disease and more symptoms than those without such exposures.

Design:

A longitudinal point prevalence study was conducted during August 17–September 4, 2020 (period 1) and during December 2–23, 2020 (period 2).

Setting:

Community based teaching health system.

Participants:

All HCWs were invited to participate. Among HCWs who acquired COVID-19, logistic regression models were used to evaluate the adjusted odds of asymptomatic disease using high-risk exposure outside the healthcare system as the explanatory variable. The number of symptoms between exposure groups was evaluated with the Wilcoxon rank-sum test. The risk of seropositivity among all HCS by work exposure was evaluated during both periods.

Interventions:

Survey and serological testing.

Result:

Seroprevalence increased from 1.9% (95% confidence interval [CI], 1.2%–2.6%) to 13.7% (95% CI, 11.9%–15.5%) during the study. Only during period 2 did HCWs with the highest work exposure (versus low exposure) have an increased risk of seropositivity (risk difference [RD], 7%; 95% CI, 1%–13%). Participants who had a high-risk exposure outside of work (compared to those without) had a decreased probability of asymptomatic disease (odds ratio [OR], 0.38; 95% CI, 0.16–0.86) and demonstrated more symptoms (median 3 [IQR, 2–6] vs 1 [IQR, 0–4]; P = .001).

Conclusions:

Healthcare-acquired COVID-19 increases the probability of asymptomatic or mild COVID-19 disease compared to community-acquired disease. This finding suggests that infection prevention strategies (including masks and eye protection) may be mitigating inoculum and supports the variolation theory in COVID-19.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 43 , Issue 4 , April 2022 , pp. 490 - 496
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bai, Y, Yao, L, Wei, T, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA 2020;323:1406–1407.CrossRefGoogle ScholarPubMed
Cevik, M, Marcus, JL, Buckee, C, Smith, TC. SARS-CoV-2 transmission dynamics should inform policy. Clin Infect Dis 2020. doi: 10.1093/cid/ciaa1442.CrossRefGoogle Scholar
Meyerowitz, EA, Richterman, A, Gandhi, RT, Sax, PE. Transmission of SARS-CoV-2: a review of viral, host, and environmental factors. Ann Intern Med 2021;174:69–79.CrossRefGoogle Scholar
Sims, MD, Maine, GN, Childers, KL, et al. COVID-19 seropositivity and asymptomatic rates in healthcare workers are associated with job function and masking. Clin Infect Dis 2020. doi: 10.1093/cid/ciaa1684.CrossRefGoogle Scholar
Jeremias, A, Nguyen, J, Levine, J, et al. Prevalence of SARS-CoV-2 infection among healthcare workers in a tertiary community hospital. JAMA Intern Med 2020. doi: 10.1001/jamainternmed.2020.4214.CrossRefGoogle Scholar
Moscola, J, Sembajwe, G, Jarrett, M, et al. Prevalence of SARS-CoV-2 antibodies in health care personnel in the New York City area. JAMA 2020;324:893–895.CrossRefGoogle ScholarPubMed
Steensels, D, Oris, E, Coninx, L, et al. Hospital-wide SARS-CoV-2 antibody screening in 3056 staff in a tertiary center in Belgium. JAMA 2020;324:195–197.CrossRefGoogle Scholar
Celebi, G, Piskin, N, Beklevic, AC, et al. Specific risk factors for SARS-CoV-2 transmission among health care workers in a university hospital. Am J Infect Control 2020;48:1225–1230.CrossRefGoogle ScholarPubMed
Godbout, EJ, Pryor, R, Harmon, M, et al. COVID-19 seroprevalence among healthcare workers in a low prevalence region. Infect Control Hosp Epidemiol 2020. doi: 10.1017/ice.2020.1374.CrossRefGoogle Scholar
Iversen, K, Bundgaard, H, Hasselbalch, RB, et al. Risk of COVID-19 in healthcare workers in Denmark: an observational cohort study. Lancet Infect Dis 2020;20:1401–1408.CrossRefGoogle ScholarPubMed
Keeley, AJ, Evans, C, Colton, H, et al. Roll-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom, March 2020. Euro Surveill 2020;25:2000433.CrossRefGoogle Scholar
Yogo, N, Greenwood, KL, Thompson, L, et al. Point-prevalence survey to evaluate the seropositivity for COVID-19 among high-risk healthcare workers. Infect Control Hosp Epidemiol 2020. doi: 10.1017/ice.2020.1370.CrossRefGoogle Scholar
Self, WH, Tenforde, MW, Stubblefield, WB, et al. Seroprevalence of SARS-CoV-2 among frontline healthcare personnel in a multistate hospital network—13 academic medical centers, April–June 2020. Morb Mortal Wkly Rep 2020;69:1221–1226.CrossRefGoogle Scholar
Fung, HF, Martinez, L, Alarid-Escudero, F, et al. The household secondary attack rate of SARS-CoV-2: a rapid review. Clin Infect Dis 2020. doi: 10.1093/cid/ciaa1558.CrossRefGoogle Scholar
Ghinai, I, Woods, S, Ritger, KA, et al. Community transmission of SARS-CoV-2 at two family gatherings—Chicago, Illinois, February–March 2020. Morb Mortal Wkly Rep 2020;69:446–450.CrossRefGoogle Scholar
Hamner, L, Dubbel, P, Capron, I, et al. High SARS-CoV-2 attack rate following exposure at a choir practice—Skagit County, Washington, March 2020. Morb Mortal Wkly Rep 2020;69:606–610.CrossRefGoogle Scholar
Madewell, ZJ, Yang, Y, Longini, IM Jr, Halloran, ME, Dean, NE. Household transmission of SARS-CoV-2: a systematic review and meta-analysis. JAMA Netw Open 2020;3:e2031756.CrossRefGoogle ScholarPubMed
Mahale, P, Rothfuss, C, Bly, S, et al. Multiple COVID-19 outbreaks linked to a wedding reception in rural Maine—August 7–September 14, 2020. Morb Mortal Wkly Rep 2020;69:1686–1690.CrossRefGoogle ScholarPubMed
von Elm, E, Altman, DG, Egger, M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453–1457.CrossRefGoogle ScholarPubMed
Trabaud, MA, Icard, V, Milon, MP, Bal, A, Lina, B, Escuret, V. Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody. J Clin Virol 2020;132:104613.CrossRefGoogle ScholarPubMed
Bajema, KL, Wiegand, RE, Cuffe, K, et al. Estimated SARS-CoV-2 seroprevalence in the US as of September 2020. JAMA Intern Med 2021;181:450–460.CrossRefGoogle ScholarPubMed
Patel, MM, Thornburg, NJ, Stubblefield, WB, et al. Change in antibodies to SARS-CoV-2 over 60 days among healthcare personnel in Nashville, Tennessee. JAMA 2020;324:1781–1782.CrossRefGoogle Scholar
Poland, GA, Ovsyannikova, IG, Kennedy, RB. SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates. Lancet 2020;396:1595–1606.CrossRefGoogle Scholar
Chu, DK, Akl, EA, Duda, S, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet 2020;395:1973–1987.CrossRefGoogle ScholarPubMed
Gandhi, M, Rutherford, GW. Facial masking for COVID-19—potential for “variolation” as we await a vaccine. N Engl J Med 2020;383:e101.CrossRefGoogle ScholarPubMed
Supplementary material: PDF

Fletcher et al. supplementary material

Fletcher et al. supplementary material

Download Fletcher et al. supplementary material(PDF)
PDF 48 KB